Graf Akcie UTHR (United Therapeutics Corp). Diskuze k akciím UTHR. Aktuální informace UTHR.

Základní informace o společnosti United Therapeutics Corp (Akcie UTHR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	8.67B
Hodnota podniku (EV)	7.76B
Tržby	1.591B
EBITDA	493.6M
Zisk	470.9M
Růst v tržbách Q/Q	23.34 %
Růst v tržbách Y/Y	11.16 %
P/E (Cena vůči ziskům)	17.77
Forward P/E	4.18
EV/Sales	4.88
EV/EBITDA	15.73
EV/EBIT	12.91
PEG	7.80
Price/Sales	5.45
P/FCF	15.42
Price/Book	2.55
Účetní hodnota na akcii	73.45
Hotovost na akcii	39.70
FCF vůči ceně	6.49 %
Počet zaměstnanců	950
Tržba na zaměstnance	1674000
Profit margin	34.71 %
Operating margin	27.90 %
Gross margin	92.71 %
EBIT margin	37.81 %
EBITDA margin	31.03 %

EPS - Zisk na akcii	10.56
EPS - Kvartální růst	51.45 %
EPS - Očekávaný růst příští rok	-7.29 %
Return on assets	10.17 %
Return on equity	13.69 %
ROIC	15.53 %
ROCE	13.27 %
Dluhy/Equity	0.36
Čistý dluh/EBITDA	-7.93
Current ratio	7.44
Quick Ratio	7.15
Volatilita	2.92
Beta	0.53
RSI	39.18
Cílová cena analytiků	155
Známka akcie (dle analytiků)	2.00
Insider ownership	N/A %
Institutional ownership	N/A %
Počet akcií	44.923M
Procento shortovaných akcií	5.60 %
Short ratio	8.18 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	1999
Země	United States

Finanční výsledky akcie UTHR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$1,483.3	$1,448.8	$1,627.8	$1,725.3	$1,598.8	$1,465.8
Cost Of Goods Sold	$108.1	$117.6	$198.7	$105.7	$72.7	$69
Gross Profit	$1,375.2	$1,331.2	$1,429.1	$1,619.6	$1,526.1	$1,396.8
Research And Development Expenses	$357.7	$1,182.6	$357.9	$264.6	$147.6	$245.1
SG&A Expenses	$423.9	$336.2	$265.8	$330.1	$316.8	$452.7
Other Operating Income Or Expenses	-	-	-	$-210	-	-
Operating Expenses	$889.7	$1,636.4	$822.4	$910.4	$537.1	$766.8
Operating Income	$593.6	$-187.6	$805.4	$814.9	$1,061.7	$699
Total Non-Operating Income/Expense	$45.3	$22.6	$-46.5	$-45.4	$-1.5	$345.4
Pre-Tax Income	$638.9	$-165	$758.9	$769.5	$1,060.2	$1,044.4
Income Taxes	$124.1	$-60.5	$169.7	$351.6	$346.5	$392.8
Income After Taxes	$514.8	$-104.5	$589.2	$417.9	$713.7	$651.6
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$514.8	$-104.5	$589.2	$417.9	$713.7	$651.6
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$514.8	$-104.5	$589.2	$417.9	$713.7	$651.6
EBITDA	$643.5	$-141.7	$841.3	$845.9	$1,093.3	$731.9
EBIT	$593.6	$-187.6	$805.4	$814.9	$1,061.7	$699
Basic Shares Outstanding	44	44	44	44	44	46
Shares Outstanding	45	44	44	45	47	51
Basic EPS	$11.65	$-2.39	$13.54	$9.50	$16.29	$14.17
EPS - Earnings Per Share	$11.54	$-2.39	$13.39	$9.31	$15.25	$12.72

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$1,835	$1,485.9	$1,415.9	$927.4	$1,050.8	$953.8
Receivables	$157.4	$151.4	$175.7	$297.1	$214.5	$192.8
Inventory	$86.5	$93.4	$101	$107.9	$100	$81.3
Pre-Paid Expenses	-	-	-	-	-	-
Other Current Assets	$88.3	$133.8	$75.4	$115.5	$59.5	$47.4
Total Current Assets	$2,167.2	$1,864.5	$1,768	$1,447.9	$1,424.8	$1,275.3
Property, Plant, And Equipment	$731.6	$738.5	$699.7	$545.7	$489.3	$495.8
Long-Term Investments	$1,149.6	$767.5	$442.6	$502.7	$2.3	$38
Goodwill And Intangible Assets	$158.1	$158.3	$170.8	$45.6	$33.8	$28.4
Other Long-Term Assets	$169.9	$154.6	$224.2	$224.1	$197.1	$154.2
Total Long-Term Assets	$2,447.8	$2,048.9	$1,633	$1,431.5	$900.8	$909.1
Total Assets	$4,615	$3,913.4	$3,401	$2,879.4	$2,325.6	$2,184.4
Total Current Liabilities	$323.3	$463	$276.6	$444.7	$332.5	$440.7
Long Term Debt	$800	$600	$250	$250	-	-
Other Non-Current Liabilities	$96.5	$70	$85.8	$82.9	$141.8	$155.1
Total Long Term Liabilities	$896.5	$670	$335.8	$332.9	$141.8	$155.1
Total Liabilities	$1,219.8	$1,133	$612.4	$777.6	$474.3	$595.8
Common Stock Net	$0.7	$0.7	$0.7	$0.7	$0.7	$0.7
Retained Earnings (Accumulated Deficit)	$3,839.2	$3,325.2	$3,434.8	$2,845.6	$2,433.5	$1,719.8
Comprehensive Income	$-14.2	$-14.2	$-7.9	$-19.6	$-16.8	$-20.4
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$3,395.2	$2,780.4	$2,788.6	$2,101.8	$1,851.3	$1,588.6
Total Liabilities And Share Holders Equity	$4,615	$3,913.4	$3,401	$2,879.4	$2,325.6	$2,184.4

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$514.8	$-104.5	$589.2	$417.9	$713.7	$651.6
Total Depreciation And Amortization - Cash Flow	$49.9	$45.9	$35.9	$31	$31.6	$32.9
Other Non-Cash Items	$131.3	$32.9	$28.9	$103.7	$15.7	$-99.6
Total Non-Cash Items	$181.2	$78.8	$64.8	$134.7	$47.3	$-66.7
Change In Accounts Receivable	$-6	$24.4	$121.4	$-82.7	$-21.7	$-30.5
Change In Inventories	$10.3	$12.9	$9.3	$-0.5	$-24.5	$-6.8
Change In Accounts Payable	$38.6	$-16.3	$-11	$66.2	$0.6	$17
Change In Assets/Liabilities	$16.8	$-201.9	$4.7	$-61.4	$-71.8	$-181.8
Total Change In Assets/Liabilities	$59.7	$-180.9	$124.4	$-78.4	$-117.4	$-202.1
Cash Flow From Operating Activities	$755.7	$-206.6	$778.4	$474.2	$643.6	$382.8
Net Change In Property, Plant, And Equipment	$-56.9	$-83.7	$-184.4	$-78	$-38	$-49.8
Net Change In Intangible Assets	-	-	-	-	-	$350
Net Acquisitions/Divestitures	-	-	$-124.1	-	$-5.2	-
Net Change In Short-term Investments	$-2,205	$-1,038.4	$-732	$-757.7	$129.6	$257.6
Net Change In Long-Term Investments	$1,523.4	$799.2	$219.9	-	$-38.1	$-54.2
Net Change In Investments - Total	$-681.6	$-239.2	$-512.1	$-757.7	$91.5	$203.4
Investing Activities - Other	-	$-12.5	-	$0.1	-	-
Cash Flow From Investing Activities	$-738.5	$-335.4	$-820.6	$-835.6	$48.3	$503.6
Net Long-Term Debt	-	-	-	-	$-8.8	$-133.2
Net Current Debt	$-50	$600	-	$250	-	-
Debt Issuance/Retirement Net - Total	$-50	$600	-	$250	$-8.8	$-133.2
Net Common Equity Issued/Repurchased	$34.8	$11.9	$19.5	$-206	$-488	$-351.2
Net Total Equity Issued/Repurchased	$34.8	$11.9	$19.5	$-206	$-488	$-351.2
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	$-1.7	$-0.7	$-13.2	$-0.7	$-0.9	$37.4
Cash Flow From Financial Activities	$-16.9	$611.2	$6.3	$43.3	$-497.7	$-447
Net Cash Flow	$0.3	$69.2	$-35.9	$-317.9	$191.2	$434.1
Stock-Based Compensation	$163.8	$45.4	$-26.4	$73.5	$12.1	$280.3
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	6.7034	4.027	6.3919	3.2559	4.2851	2.8938
Long-term Debt / Capital	0.1907	0.1775	0.0823	0.1063	-	-
Debt/Equity Ratio	0.2356	0.3057	0.0897	0.1189	-	-
Gross Margin	92.7122	91.8829	87.7933	93.8735	95.4528	95.2927
Operating Margin	40.0189	-12.9486	49.4778	47.2324	66.4061	47.6873
EBIT Margin	40.0189	-12.9486	49.4778	47.2324	66.4061	47.6873
EBITDA Margin	43.383	-9.7805	51.6833	49.0292	68.3825	49.9318
Pre-Tax Profit Margin	43.0729	-11.3887	46.6212	44.6009	66.3122	71.2512
Net Profit Margin	34.7064	-7.2129	36.1961	24.2219	44.6397	44.4535
Asset Turnover	0.3214	0.3702	0.4786	0.5992	0.6875	0.671
Inventory Turnover Ratio	1.2497	1.2591	1.9673	0.9796	0.727	0.8487
Receiveable Turnover	9.4238	9.5694	9.2647	5.8071	7.4536	7.6027
Days Sales In Receivables	38.7319	38.1426	39.397	62.8537	48.9695	48.0093
ROE - Return On Equity	15.1626	-3.7585	21.1289	19.883	38.5513	41.0173
Return On Tangible Equity	15.9031	-3.9854	22.5075	20.3239	39.2682	41.7639
ROA - Return On Assets	11.1549	-2.6703	17.3243	14.5134	30.6889	29.8297
ROI - Return On Investment	12.2712	-3.0914	19.3905	17.7694	38.5513	41.0173
Book Value Per Share	76.2846	63.3565	63.9763	48.6078	43.0876	34.7152
Operating Cash Flow Per Share	21.6609	-22.4078	7.1296	-3.1908	6.2755	0.9212
Free Cash Flow Per Share	22.2961	-20.1279	4.6759	-4.1161	6.4363	0.8231

Premium

Tento článek patří k prémiovému obsahu našeho webu.

Již mám předplatné

Roční předplatné

Ušetříte 589 Kč oproti měsíčnímu předplatnému

2 999Kč

Objednat

Čtvrtletní předplatné

Ušetříte 98 Kč oproti měsíčnímu předplatnému

799Kč

Objednat

Měsíční předplatné

Předplatné našich prémiových služeb na měsíc.

299Kč

Objednat

Porovnání s konkurencí: Akcie UTHR

Společnost	P/E	PEG	Růst v tržbách (roční)	Růst v EPS	Return on equity	P/B	Profit margin
UTHR	17.77	7.80	11.16 %	-7.29 %	13.69 %	2.55	34.71 %
Akcie BAX	35.90	1.49	N/A %	13.25 %	13.10 %	4.62	9.44 %
Akcie CYTK	N/A	N/A	209.34 %	1,440.00 %	-179.39 %	23.34	-228.00 %
Akcie GSK	16.60	3.36	N/A %	-14.00 %	29.69 %	4.85	16.86 %
Akcie GILD	16.42	0.56	20.13 %	-20.85 %	27.79 %	4.69	0.50 %
Akcie CAH	23.22	4.22	6.24 %	-7.95 %	35.04 %	7.89	0.38 %
Akcie LLY	35.62	1.63	16.46 %	27.92 %	101.98 %	39.72	25.24 %
Akcie PFE	17.66	1.97	4.96 %	50.00 %	19.81 %	3.72	22.95 %
Akcie TEVA	N/A	0.79	-0.96 %	12.07 %	-39.21 %	1.08	-23.95 %

Nedávné obchody insiderů: Akcie UTHR

Jméno	Obchod	Cena	Objem
Christopher Causey Director	Option 23 Dec 2020	$88.03	$132,045
Christopher Causey Director	Option 31 Dec 2020	$88.03	$660,225
Richard Giltner Director	Option 4 Jan 2021	$48.11	$240,550
Christopher Causey Director	Option 5 Jan 2021	$88.03	$132,045
Richard Giltner Director	Option 6 Jan 2021	$48.11	$481,100
Christopher Causey Director	Option 6 Jan 2021	$88.03	$264,090
Paul A Mahon EVP and General Counsel	Option 7 Jan 2021	$94.96	$569,760
Christopher Causey Director	Option 15 Jan 2021	$88.03	$132,045
Paul A Mahon EVP and General Counsel	Option 21 Jan 2021	$94.96	$569,760
Paul A Mahon EVP and General Counsel	Option 4 Feb 2021	$94.96	$569,760
Paul A Mahon EVP and General Counsel	Option 18 Feb 2021	$94.96	$569,760

JenAkcie

Graf Akcie UTHR (United Therapeutics Corp). Diskuze k akciím UTHR. Aktuální informace UTHR.

Základní informace o společnosti United Therapeutics Corp (Akcie UTHR)

Finanční výsledky akcie UTHR

Tento článek patří k prémiovému obsahu našeho webu.

Roční předplatné

Čtvrtletní předplatné

Měsíční předplatné

Porovnání s konkurencí: Akcie UTHR

Nedávné obchody insiderů: Akcie UTHR

Diskuze k akciím UTHR